Only 2 weeks left! Frost & Sullivan invites you to join the Synthetic Biology and Biomanufacturing Forum to embark on a new journey in industrial development

Today, biomanufacturing has become a prominent gem in the capital market. Synthetic biology, as the third life science revolution following the discovery of the DNA double helix structure and the genome technology revolution, is driving the biomanufacturing industry to rapidly enter the 4.0 era, serving as a crucial strategic pillar for reshaping global material production methods. In the future, it will deeply transform the development paradigms of the biomedical, advanced materials, consumer goods, energy, environmental protection, and agriculture industries. Developing synthetic biology and biomanufacturing industries is not only a strategic opportunity to seize global leadership positions but also an important path to accelerate the formation of new productive forces and achieve high-level technological self-sufficiency.

On August 4, Frost & Sullivan, the 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 5th New Investment Conference, will be hosted, and a special forum on synthetic biology and biomanufacturing will be launched for the first time. Registration for the forum is now open.

As a core professional forum focusing on cutting-edge biotech at this summit, the Synthetic Biology and Biomanufacturing Forum will bring together academicians from two academies, top scholars, university professors, industry experts, leading enterprises, and investment institutions. Through keynote speeches, panel discussions, and white paper releases, a integrated communication platform of “industry-university-research-finance-usage-service” will be established. This forum will comprehensively showcase the industrial value of the “third biotechnology revolution” in synthetic biology, providing strong support for technological innovation, achievement transformation, ecosystem improvement, and global development of China’s biomanufacturing industry.

Scan the QR code to register and attend immediately

Frost & Sullivan will continue the research project of the ‘Shanghai Synthetic Biology and Biomanufacturing Industry Development White Paper (2025)’ from last year, and jointly release the ‘Global and Chinese Synthetic Biology and Biomanufacturing Industry Development White Paper (2026)’ for the first time with the National Biomanufacturing Industry Innovation Center. This white paper will systematically outline the global development landscape of synthetic biology and biomanufacturing industries. Through close cooperation of “government-industry-university-research-finance-usage-service” and in-depth research results, it aims to provide forward-looking structured insights and references for government agencies, investment institutions, the industry, and all sectors of society.

Specifically, regarding chapters on the upstream and downstream of the industry chain and benchmark cases (parks, enterprises, industry platforms, etc.), relevant enterprises are invited to cooperate. They will share from a first-person perspective how to address existing challenges and capitalize on business opportunities, demonstrating their core competencies such as business models, technical platforms, advanced processes, and ecological partnerships. These empirical cases will provide authoritative voices and focused dissemination channels for partner enterprises, while also offering references for investors, research institutions, and the industry, attracting upstream and downstream partners to join the enterprise ecosystem. Participating in this white paper project helps partner enterprises enhance their brand presence in the global market and support global brand building and product layout.

Two strategic cooperation agreements will be held at this forum to promote deep integration of “industry-university-research-usage” and overcome barriers to innovative development in the synthetic biology field. At the forum, Frost & Sullivan will officially sign a strategic cooperation agreement with the National Biomanufacturing Industry Innovation Center. Based on the development needs of synthetic biology and biomanufacturing industries, both parties will focus on core areas such as technological innovation implementation, industry ecosystem construction, industry research empowerment, and project achievement transformation, carrying out comprehensive and in-depth long-term strategic cooperation to jointly promote high-quality upgrading of the synthetic biology and biomanufacturing industries.

At the same time, Frost & Sullivan will also hold school-enterprise strategic cooperation agreement ceremonies with the University of Electronic Science and Technology of China and Fudan University, fully integrating industry service advantages and top academic research and talent resources from universities to build a dedicated industry-university-research collaborative innovation system. They will focus on core areas such as AI+BIO frontier technology research, innovation achievement implementation, joint talent training, and industry innovation application exploration, striving to overcome technical bottlenecks and industry pain points in the integration of AI and biomanufacturing, and officially starting a new chapter of mutual empowerment between schools and enterprises in AI*BIO innovative development.

Two important panel discussions will be held at this forum, bringing together industry leaders, innovative enterprises, and frontline investment institutions to conduct in-depth discussions and intellectual exchanges around two cutting-edge topics.

Focusing on investment opportunities and real challenges in the synthetic biology and biomanufacturing sector, this discussion will explore sustainable development paths for the industry. The panel includes representatives from innovative enterprises and industrial capital, including leading companies in various fields such as Yucan Biotech, Huaxi Tang'an Biotechnology, and Juweiyuanchuang, as well as relevant national guidance fund institutions. Guests will analyze the development bottlenecks of biomanufacturing projects from a capital perspective and frontline industrialization practice, exploring investment logic and solutions that balance long-term technology research and commercialization.

This panel discussion will focus on the integration trends of AI and synthetic biology, discussing application scenarios, innovation opportunities, and development boundaries of AI&BIO technologies. Leading enterprises in the industry such as Yingxi Intelligent, Enhe Biotech, and Abio Yi, along with professional investment institutions like Lenovo Venture Capital, will participate in the discussion. All parties will rely on project practices and forward-looking investment perspectives to discuss how AI can reshape the bioresearch chain and accelerate innovation achievement transformation, uncovering new growth opportunities in cross-sectoral markets.

📞 Conference Consultation Hotline:

021-3209-6800 ext. 8672

📧 Conference Consultation Email:

gil@frostchina.com